ArticleTransplantation and cellular therapy2022

Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885].

Saurabh Chhabra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.